// App-Quantinova.ai

542 2014 HTN : Blockade of Angiotensin-(1-7)-mediated Vascular Remodeling by a CB2 Cannabinoid Receptor Antagonist

Researchers

Presenter

  • Allyn C Howlett

Principal Investigators

  • Patricia E Gallagher

Medical Centers

  • Wake Forest School of Medicine, Winston-Salem, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Angiology

Disease

  • Hypertrophic cardiomyopathy

  • Calcified vascular disease

Biomarkers

  • B-type natriuretic peptide

Drug/Treatment

  • Angiotensin II

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved